We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+0.58%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$346B
AUM Growth
-$1.37B
Cap. Flow
+$1.39B
Cap. Flow %
0.4%
Top 10 Hldgs %
14.49%
Holding
5,584
New
478
Increased
2,283
Reduced
2,044
Closed
441

Sector Composition

Rank Sector Weight
1 Technology 13.44%
2 Financials 10.55%
3 Healthcare 8.78%
4 Consumer Discretionary 7.66%
5 Industrials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AREC icon
5001
American Resources Corp
AREC
$196M
$38K ﹤0.01%
+65,060
New +$129K
HBIO icon
5002
Harvard Bioscience
HBIO
$27.5M
$36K ﹤0.01%
1,164
-26,832
-96% -$667K
VHI icon
5003
Valhi
VHI
$391M
$36K ﹤0.01%
1,600
-144
-8% -$3.68K
CFMS
5004
DELISTED
Conformis, Inc. Common Stock
CFMS
$36K ﹤0.01%
766
-523
-41% -$31.4K
SCOR icon
5005
Comscore
SCOR
$112M
$35K ﹤0.01%
920
-12,849
-93% -$742K
ARTL icon
5006
Artelo Biosciences
ARTL
$2.63M
$34K ﹤0.01%
+58
New +$44.2K
CRIS icon
5007
Curis
CRIS
$9.67M
$33K ﹤0.01%
37
ISEE
5008
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$33K ﹤0.01%
+29,370
New +$34.2K
AQST icon
5009
Aquestive Therapeutics
AQST
$467M
$32K ﹤0.01%
+10,209
New +$38.3K
UONEK icon
5010
Urban One Class D
UONEK
$22.1M
$32K ﹤0.01%
1,662
+610
+58% +$12.1K
LUMO
5011
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$32K ﹤0.01%
2,268
-20,936
-90% -$307K
TOVX icon
5012
Theriva Biologics
TOVX
$9.64M
$30K ﹤0.01%
268
+223
+496% +$26.9K
PHLT
5013
DELISTED
Performant Healthcare Inc
PHLT
$30K ﹤0.01%
27,655
-6,101
-18% -$7.18K
SPAQ.WS
5014
DELISTED
Spartan Energy Acquisition Corp. Warrants, each whole warrant exercisable for one Class A common sto
SPAQ.WS
$29K ﹤0.01%
48,333
AAC
5015
DELISTED
AAC Holdings
AAC
$29K ﹤0.01%
43,646
-52,797
-55% -$44.1K
PFX icon
5016
PhenixFIN
PFX
$83.1M
$28K ﹤0.01%
+533
New +$27.6K
ZVRA icon
5017
Zevra Therapeutics
ZVRA
$570M
$28K ﹤0.01%
+2,507
New +$45.3K
CRR
5018
DELISTED
Carbo Ceramics Inc.
CRR
$28K ﹤0.01%
11,707
-1,602
-12% -$2.56K
PFSW
5019
DELISTED
PFSweb, Inc.
PFSW
$28K ﹤0.01%
11,205
-2,603
-19% -$7.98K
STKL
5020
CALL
DELISTED
SunOpta
STKL
$27K ﹤0.01%
15,000
-15,500
-51% -$40.2K
CHRA
5021
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$27K ﹤0.01%
1,283
-740
-37% -$29.2K
ESTRW
5022
DELISTED
Estre Ambiental, Inc
ESTRW
$26K ﹤0.01%
661,870
TDW.WS.A
5023
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
$25K ﹤0.01%
16,997
+3,367
+25% +$7.49K
HSACW
5024
DELISTED
Health Sciences Acquisitions Corporation Warrants
HSACW
$25K ﹤0.01%
+29,180
New +$26.6K
ZVO
5025
DELISTED
Zovio Inc. Common Stock
ZVO
$23K ﹤0.01%
11,809
-6,022
-34% -$18.1K

Similar funds

Goldman Sachs's Q3 2019 Portfolio in Review

As of Q3 2019, Goldman Sachs held 5,584 positions worth $346B, down 0.39% from $347B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Goldman Sachs's Q3 2019 filing shows 478 new, 2,283 increased, 2,044 reduced and 441 closed positions. Its largest new stake was ProSight Global, Inc.: 17,005,092 shares worth $329M. The largest sale was Anadarko Petroleum, an estimated $688M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Goldman Sachs's largest Q3 2019 buy was ProSight Global, Inc.: 17,005,092 shares worth $329M.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.87B increase.
  • Goldman Sachs's biggest Q3 2019 reduction was Blackstone, cutting an estimated $416M.
  • Goldman Sachs fully exited Anadarko Petroleum in Q3 2019, selling an estimated $688M.
  • Goldman Sachs's ten largest holdings make up 14% of its $346B portfolio in Q3 2019.
  • Goldman Sachs opened 478 new positions and closed 441 in Q3 2019.
  • Goldman Sachs's portfolio value fell 0.39% quarter-over-quarter to $346B.

Based on Goldman Sachs's 13F filing for Q3 2019, filed 14 Nov 2019.